Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,079,680    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,018,530      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $910,988 Immunome Inc. $140,283 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $910,988 Immunome Inc. $140,283
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 25 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-03 4 AS $36.68 $366,800 D/D (10,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-03 4 OE $9.86 $98,600 D/D 10,000 123,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-04 4 OE $9.86 $98,600 D/D 10,000 123,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-04 4 AS $36.00 $360,000 D/D (10,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-22 4 AS $55.00 $550,000 D/D (10,000) 157,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 OE $12.99 $129,900 I/I 10,000 30,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 AS $68.55 $685,477 I/I (10,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-04 4 OE $12.99 $129,900 I/I 10,000 53,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-04 4 OE $60.72 $607,194 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-05 4 OE $12.99 $129,900 I/I 10,000 53,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-05 4 OE $58.68 $593,406 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-31 4 OE $12.99 $129,900 I/I 10,000 55,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-31 4 AS $62.72 $627,155 I/I (10,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-24 4 AS $68.71 $687,143 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-24 4 A $12.99 $129,900 I/I 10,000 60,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-06 4 AS $67.40 $674,096 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-06 4 OE $12.99 $129,900 I/I 10,000 60,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-05 4 S $113.70 $1,137,016 I/I (10,000) 42,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-05 4 OE $12.99 $129,900 I/I 10,000 52,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-01 4 AS $84.22 $842,769 D/D (10,000) 340,500 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 OE $80.15 $801,489 I/I 10,000 0 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-28 4 OE $38.59 $385,900 D/D 10,000 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-28 4 AS $89.89 $898,912 D/D (10,000) 225,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-29 4 AS $89.61 $896,125 D/D (10,000) 225,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-29 4 OE $38.59 $385,900 D/D 10,000 235,894 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25  26   27   28   29   30   31   32   33   34   35      
  Page 25 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us